| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.77B | +15.3% |
| Cost of Revenue | $1.47B | +17.1% |
| Gross Profit | $1.30B | +13.3% |
| R&D Expense | $185.0M | +8.2% |
| SG&A Expense | $328.0M | +7.5% |
| Operating Income | $784.0M | +17.2% |
| Pre-tax Income | $645.0M | +12.8% |
| Income Tax | $114.0M | -12.3% |
| Net Income | $531.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $232.0M | +82.7% |
| Accounts Receivable | $363.0M | +20.6% |
| Inventory | $224.0M | +9.8% |
| Current Assets | $866.0M | +29.1% |
| Total Assets | $4.67B | +4.8% |
| Current Liabilities | $480.0M | +4.6% |
| Long-term Debt | $2.52B | -0.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $657.0M | +3.5% |
| Capital Expenditures | $167.0M | -4.6% |
| Investing Cash Flow | -$183.0M | +13.7% |
| Financing Cash Flow | -$367.0M | +39.2% |
| Free Cash Flow | $490.0M | +6.5% |
| +20.1% |
| EPS (Basic) | $5.53 | +33.9% |
| EPS (Diluted) | $5.53 | +33.9% |
| Total Liabilities |
| $3.80B |
| -0.7% |
| Stockholders' Equity | $874.0M | +37.9% |